Travere Therapeutics (TVTX)

• Market cap: $3.17B
• 1 day: -2.23%
• 5 days: 2.16%
• 1 month: 18.92%
• 3 months: 100.28%
• 6 months: 137.12%
• Year to date: 86.87%
• 1 year: 88.46%
• 5 years: 54.6%
• 10 years: 58.61%
• Sector: Healthcare
• Industry: Biotechnology

About: Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Employees: 385